to-BBB technologies
Latest round
- Series C
Last raised
- Jun 2014
Total raised
- $24M
Investors
- 4
About to-BBB technologies
Founded in 2003 and headquartered in Leiden, Netherlands, to-BBB technologies BV develops advanced drug delivery systems.V. specializes in the development of advanced drug delivery systems specifically targeting brain and eye diseases. The company's core offerings include proprietary formulations based on G-Technology®, which employs CNS-targeted liposomes to enhance the delivery of therapeutics across the blood-brain barrier and blood-retina barrier. With two lead programs currently in clinical development—2B3-101 for brain cancer and 2B3-201 for neuro-inflammatory diseases—2-BBB aims to address critical unmet medical needs in these challenging areas. The end-users of these products primarily comprise patients suffering from debilitating neurological conditions, as well as healthcare providers seeking innovative treatment options.V. is structured around partnerships and collaborations within the pharmaceutical industry, focusing on B2B transactions. The company engages with pharmaceutical firms or research institutions to co-develop and commercialize its proprietary drug delivery technologies. Revenue generation stems from licensing agreements or joint ventures related to its flagship programs, including 2B3-101 and 2B3-201, involving upfront payments, milestone payments upon achieving clinical or regulatory targets, and royalties on sales post-commercialization. The company is focused on expanding its market reach and aims to penetrate new geographic markets where demands for CNS and ocular disorder treatments exist.
Who invested in to-BBB technologies
4 investors across 4 rounds
See all investors in to-BBB technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about to-BBB technologies
Who invested in to-BBB technologies?
to-BBB technologies has 4 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has to-BBB technologies raised?
to-BBB technologies has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did to-BBB technologies last raise money?
to-BBB technologies's most recent round on record is a Series C, in Jun 2014.
What does to-BBB technologies do?
Founded in 2003 and headquartered in Leiden, Netherlands, to-BBB technologies BV develops advanced drug delivery systems.
Where is to-BBB technologies headquartered?
to-BBB technologies is headquartered in Leiden, Netherlands.
Which VCs invest in companies like to-BBB technologies?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at to-BBB technologies's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like to-BBB technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.